Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 26

1.

Second window of preconditioning normalizes palmitate use for oxidation and improves function during low-flow ischaemia.

Kudej RK, Fasano M, Zhao X, Lopaschuk GD, Fischer SK, Vatner DE, Vatner SF, Lewandowski ED.

Cardiovasc Res. 2011 Dec 1;92(3):394-400. doi: 10.1093/cvr/cvr215. Epub 2011 Aug 11.

2.

Protection of the ischaemic heart: investigations into the phenomenon of ischaemic preconditioning.

Lochner A, Marais E, Genade S, Huisamen B, du Toit EF, Moolman JA.

Cardiovasc J Afr. 2009 Jan-Feb;20(1):43-51. Review.

3.

Consequences of brief ischemia: stunning, preconditioning, and their clinical implications: part 1.

Kloner RA, Jennings RB.

Circulation. 2001 Dec 11;104(24):2981-9. Review.

4.

[Hibernation, stunning, ischemic preconditioning--new paradigms in coronary disease?].

Heusch G.

Z Kardiol. 1992 Nov;81(11):596-609. Review. German.

PMID:
1471397
5.

Dihydropyridine calcium antagonists: beneficial or adverse effects in the setting of myocardial ischaemia/reperfusion?

Ehring T, Heusch G.

Cardiology. 1997;88 Suppl 1:3-14; discussion 15-6. Review.

PMID:
9118166
6.

Balance and imbalance of regional myocardial contractile function and blood flow.

Schulz R, Heusch G.

Z Kardiol. 2001 Dec;90(12):964-9. Review.

PMID:
11826838
7.

Remote ischaemic preconditioning: underlying mechanisms and clinical application.

Hausenloy DJ, Yellon DM.

Cardiovasc Res. 2008 Aug 1;79(3):377-86. doi: 10.1093/cvr/cvn114. Epub 2008 May 2. Review.

PMID:
18456674
8.
9.

Cardioprotection acquired through exercise: the role of ischemic preconditioning.

Marongiu E, Crisafulli A.

Curr Cardiol Rev. 2014 Nov;10(4):336-48. Review.

10.

Exercise preconditioning of the myocardium.

Kavazis AN.

Sports Med. 2009;39(11):923-35. doi: 10.2165/11317870-000000000-00000. Review.

PMID:
19827860
11.

Hibernating, stunning and ischemic preconditioning of the myocardium: therapeutic implications.

Niroomand F, Kübler W.

Clin Investig. 1994 Oct;72(10):731-6. Review.

PMID:
7865974
12.

The concept of anaesthetic-induced cardioprotection: mechanisms of action.

Weber NC, Schlack W.

Best Pract Res Clin Anaesthesiol. 2005 Sep;19(3):429-43. Review.

PMID:
16013692
13.

Metabolic fingerprint of ischaemic cardioprotection: importance of the malate-aspartate shuttle.

Nielsen TT, Støttrup NB, Løfgren B, Bøtker HE.

Cardiovasc Res. 2011 Aug 1;91(3):382-91. doi: 10.1093/cvr/cvr051. Epub 2011 Feb 23. Review.

PMID:
21349875
14.

Hibernating myocardium.

Heusch G.

Physiol Rev. 1998 Oct;78(4):1055-85. Review.

PMID:
9790569
15.

Ischemic preconditioning: the endogenous power--a review of the literature.

Alsaddique AA.

Angiology. 2000 May;51(5):355-60. Review.

PMID:
10826851
16.

Ischemic preconditioning and myocardial stunning: related consequences of brief coronary occlusion and reperfusion?

Schott RJ, Schaper W.

Adv Cardiol. 1990;37:32-41. Review. No abstract available.

PMID:
2220460
17.

Autophagy, myocardial protection, and the metabolic syndrome.

Giricz Z, Mentzer RM Jr, Gottlieb RA.

J Cardiovasc Pharmacol. 2012 Aug;60(2):125-32. doi: 10.1097/FJC.0b013e318256ce10. Review.

18.

Myocardial stunning in man.

Barnes E, Khan MA.

Heart Fail Rev. 2003 Apr;8(2):155-60. Review.

PMID:
12766494
19.

Myocardial stunning in the neonate.

Booker PD.

Br J Anaesth. 1998 Mar;80(3):371-83. Review. No abstract available.

20.

Protective effects of anaesthetics in reversible and irreversible ischaemia-reperfusion injury.

Ross S, Foëx P.

Br J Anaesth. 1999 Apr;82(4):622-32. Review. No abstract available.

Supplemental Content

Support Center